Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-09 5:41 pm Purchase | 2026-06-06 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 93,845,778 23.900% | 402,991 (+0.43%) | Filing History |
| 2026-06-04 6:36 pm Unchanged | 2026-06-04 | 13G | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 4,757,165 9.700% | 0 (Unchanged) | Filing History |
| 2026-05-22 6:37 pm Sale | 2026-05-20 | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 4,757,165 9.700% | -1,200,000 (-20.14%) | Filing History |
| 2026-02-17 4:47 pm Unchanged | 2025-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital, LLC | 13,003,574 7.500% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:45 pm Purchase | 2025-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital, LLC | 13,003,574 7.500% | 5,615,631 (+76.01%) | Filing History |
| 2025-11-28 5:33 pm Purchase | 2025-11-25 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 93,442,787 24.200% | 12,578,472 (+15.56%) | Filing History |
| 2025-11-14 5:14 pm Sale | 2025-09-30 | 13G | CODEXIS INC CDXS | Casdin Capital, LLC | 0 0.000% | -7,200,000 (Position Closed) | Filing History |
| 2025-10-17 8:04 pm Sale | 2025-10-15 | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 5,957,165 12.400% | -750,000 (-11.18%) | Filing History |
| 2025-08-21 9:35 pm Sale | 2025-08-15 | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 6,707,165 14.000% | -500,000 (-6.94%) | Filing History |
| 2025-08-14 4:34 pm Sale | 2025-06-30 | 13G | CODEXIS INC CDXS | Casdin Capital, LLC | 7,200,000 8.700% | -900,000 (-11.11%) | Filing History |
| 2025-08-13 7:00 pm Sale | 2025-08-11 | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 7,207,165 15.000% | -500,000 (-6.49%) | Filing History |
| 2025-06-12 9:10 pm Sale | 2025-06-10 | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 7,707,165 16.200% | -1,027,994 (-11.77%) | Filing History |
| 2025-05-15 4:27 pm Sale | 2025-03-31 | 13G | CENTURY THERAPEUTICS INC IPSC | Casdin Capital, LLC | 3,212,316 3.700% | -1,380,000 (-30.05%) | Filing History |
| 2025-04-09 5:13 pm Purchase | 2025-04-07 | 13D | BIOLIFE SOLUTIONS INC BLFS | Casdin Capital, LLC | 8,735,159 18.500% | 27,994 (+0.32%) | Filing History |
| 2025-03-07 8:22 pm Purchase | 2025-03-04 | 13D | TENAYA THERAPEUTICS INC TNYA | Casdin Capital, LLC | 6,732,971 4.300% | 305,771 (+4.76%) | Filing History |
| 2025-03-04 7:46 pm Purchase | 2025-02-28 | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital, LLC | 80,864,315 21.600% | 7,098,241 (+9.62%) | Filing History |
| 2025-02-14 4:00 pm Purchase | 2024-12-31 | 13G | NEUROGENE INC NGNE | Casdin Capital, LLC | 1,295,361 8.700% | 270,745 (+26.42%) | Filing History |
| 2024-11-27 6:51 pm Purchase | 2024-11-20 | 13G | CENTURY THERAPEUTICS INC IPSC | Casdin Capital, LLC | 4,592,316 5.400% | 1,380,000 (+42.96%) | Filing History |
| 2024-11-14 4:08 pm Sale | 2024-09-30 | 13G | CENTURY THERAPEUTICS INC IPSC | Casdin Capital, LLC | 3,212,316 3.800% | -1,978,190 (-38.11%) | Filing History |
| 2024-11-08 4:33 pm Purchase | 2024-11-04 | 13G | NEUROGENE INC NGNE | Casdin Capital, LLC | 1,024,616 6.900% | 1,024,616 (New Position) | Filing History |